HelixNano

About:

Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases.

Website: http://helixnano.com/

Twitter/X: HelixNano

Top Investors: Alumni Ventures, Y Combinator, Saya Bio, DCVC, Lifeline Ventures

Description:

Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases. HelixNano is a Y Combinator and venture backed biotech startup. At HelixNano, we have spent the last two years developing cancer vaccines. Now we are adapting our synthetic biology arsenal to take on COVID-19. We’re moving fast but thinking long-term. We’re already testing COVID-19 vaccine candidates designed to be precise and safe. Our next goal is to create a vaccine that protects everyone not only from this virus, but all future coronaviruses.

Total Funding Amount:

$59.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)helixnano.com

Founders:

Hannu Rajaniemi, Nikolai Eroshenko

Number of Employees:

1-10

Last Funding Date:

2024-04-04

IPO Status:

Private

© 2024 MyAiNote.com